Thomas C Luke
Overview
Explore the profile of Thomas C Luke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Poland G, Fleming D, Treanor J, Maraskovsky E, Luke T, Ball E, et al.
Vaccine
. 2013 Apr;
31 Suppl 1:A1-20.
PMID: 23587330
Both seasonal and pandemic influenza cause considerable morbidity and mortality globally. In addition, the ongoing threat of new, unpredictable influenza pandemics from emerging variant strains cannot be underestimated. Recently bioCSL...
12.
Defang G, Martin N, Burgess T, Millar E, Pecenka L, Danko J, et al.
PLoS One
. 2013 Jan;
7(12):e48229.
PMID: 23284613
Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the...
13.
Richie T, Charoenvit Y, Wang R, Epstein J, Hedstrom R, Kumar S, et al.
Hum Vaccin Immunother
. 2012 Nov;
8(11):1564-84.
PMID: 23151451
When introduced in the 1990s, immunization with DNA plasmids was considered potentially revolutionary for vaccine development, particularly for vaccines intended to induce protective CD8 T cell responses against multiple antigens....
14.
15.
Luke T, Casadevall A, Watowich S, Hoffman S, Beigel J, Burgess T
Crit Care Med
. 2010 Feb;
38(4 Suppl):e66-73.
PMID: 20154602
The world is experiencing a pandemic of swine-origin influenza virus H1N1. A vaccine to prevent disease is now available, and millions have or will become ill before they can be...
16.
Luke T, Rodrigue J
Am J Disaster Med
. 2008 Jun;
3(2):99-107.
PMID: 18522251
The H5N1 influenza threat is resulting in global preparations for the next influenza pandemic. Pandemic influenza planners are prioritizing scarce vaccine, antivirals, and public health support for different segments of...
17.
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?
Luke T, Kilbane E, Jackson J, Hoffman S
Ann Intern Med
. 2006 Aug;
145(8):599-609.
PMID: 16940336
Background: Studies from the Spanish influenza era reported that transfusion of influenza-convalescent human blood products reduced mortality in patients with influenza complicated by pneumonia. Treatments for H5N1 influenza are unsatisfactory,...
18.
Luke T, Hoffman S
J Exp Biol
. 2003 Sep;
206(Pt 21):3803-8.
PMID: 14506215
Annually, malaria causes >300 million clinical cases and 1 million deaths, is responsible for the loss of >1% of gross domestic product (GDP) in Africa and is a serious concern...
19.
Hoffman S, Goh L, Luke T, Schneider I, Le T, Doolan D, et al.
J Infect Dis
. 2002 Apr;
185(8):1155-64.
PMID: 11930326
During 1989-1999, 11 volunteers were immunized by the bites of 1001-2927 irradiated mosquitoes harboring infectious sporozoites of Plasmodium falciparum (Pf) strain NF54 or clone 3D7/NF54. Ten volunteers were first challenged...